Invivyd (IVVD) Total Liabilities (2020 - 2025)
Invivyd (IVVD) reported Total Liabilities of $35.3 million for Q4 2025, down 42.97% on a YoY basis from $62.0 million in Q4 2024, and down 23.32% quarter-over-quarter from $46.1 million in Q3 2025.
Invivyd (IVVD) Total Liabilities (2020 - 2025) Analysis & Trends
Invivyd has reported Total Liabilities for 6 years, with the latest figure at $35.3 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities fell 42.97% year-over-year to $35.3 million; the trailing twelve-month figure through Dec 2025 stood at $35.3 million (down 42.97% YoY), and the FY2025 full-year result was $35.3 million, down 42.97% from the prior year.
- Total Liabilities for Q4 2025 stood at $35.3 million, down from $46.1 million in the prior quarter.
- The five-year high for Total Liabilities was $103.4 million in Q1 2021, with the low at $23.8 million in Q1 2023.
- Historically, Total Liabilities has averaged $51.4 million across 5 years, with a median of $46.8 million in 2022.
- Annual changes were most pronounced in 2021 — Total Liabilities jumped 374.45% — and 2023, when it slumped 75.42%.
- Invivyd's Total Liabilities stood at $62.1 million in 2021, then slumped by 56.18% to $27.2 million in 2022, then surged by 90.14% to $51.7 million in 2023, then rose by 19.85% to $62.0 million in 2024, then sank by 42.97% to $35.3 million in 2025.
- The last three Total Liabilities figures came in at $35.3 million (Q4 2025), $46.1 million (Q3 2025), and $46.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 35.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.34 Mn |
| Sep 30, 2025 | 46.09 Mn |
| Jun 30, 2025 | 46.35 Mn |
| Mar 31, 2025 | 49.60 Mn |
| Dec 31, 2024 | 61.98 Mn |
| Sep 30, 2024 | 78.76 Mn |
| Jun 30, 2024 | 36.70 Mn |
| Mar 31, 2024 | 36.97 Mn |
| Dec 31, 2023 | 51.71 Mn |
| Sep 30, 2023 | 28.42 Mn |
| Jun 30, 2023 | 33.85 Mn |
| Mar 31, 2023 | 23.82 Mn |
| Dec 31, 2022 | 27.20 Mn |
| Sep 30, 2022 | 47.30 Mn |
| Jun 30, 2022 | 69.77 Mn |
| Mar 31, 2022 | 96.88 Mn |
| Dec 31, 2021 | 62.07 Mn |
| Sep 30, 2021 | 53.06 Mn |
| Jun 30, 2021 | 37.91 Mn |
| Mar 31, 2021 | 103.36 Mn |